1,381
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma

, , , , , , , , , & show all
Pages 1139-1147 | Received 20 Jun 2017, Accepted 29 Jul 2017, Published online: 11 Aug 2017

References

  • Burma S, Chen BP, Murphy M, et al. (2001). ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276:42462–7.
  • Cavaletti G, Alberti P, Marmiroli P. (2011). Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol 12:1151–61.
  • Denny L. (2012). Cervical cancer: prevention and treatment. Discov Med 14:125–31.
  • Fang F, Gong C, Qian Z, et al. (2009). Honokiol nanoparticles in thermosensitive hydrogel: Therapeutic effects on malignant pleural effusion. Acs Nano 3:4080–8.
  • Gong C, Xie Y, Wu Q, et al. (2012). Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Nanoscale 4:6004–17.
  • Gong CY, Shi S, Dong PW, et al. (2009). Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm 365:89–99.
  • Hashemi FA, Akbari EH, Kalaghchi B, Esmati E. (2013). Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer. Asian Pacific J Cancer Prevent 14:5385.
  • Hong Y, Zhang C, Li X, et al. (2013). HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. Neuroscience 13:1–8.
  • Lei N, Gong C, Qian Z, et al. (2012). Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model. Nanoscale 4:5686–93.
  • Lin Z, Gao W, Hu H, et al. (2014). Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J Control Release 174:161–70.
  • Matsuoka S, Ballif BA, Smogorzewska A 3rd, et al. (2007). ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–6.
  • Mccormack M, Kadalayil L, Hackshaw A, et al. (2013). A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. Br J Cancer 108:2464–9.
  • Mousavia AS, Vahidi S, Karimizarchi M, et al. (2013). Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer. Eur J Gynaecol Oncol 34:527–31.
  • Pisano C, Pratesi G, Laccabue D, et al. (2003). Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res 9:5756–67.
  • Roudsari LC, West JL. (2016). Studying the influence of angiogenesis in in vitro cancer model systems. Adv Drug Deliv Rev 97:250–9.
  • Rowinsky EK, Donehower RC. (1995). Paclitaxel (taxol). N Engl J Med 332:1004–14.
  • Shuang L, Ting H, Weiguo L, et al. (2013). Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group. Oncologist 18:1101–7.
  • Song Y, Li G, Zhu F, et al. (2007). Clinical study of paclitaxel plus cisplatin in the treatment of recurrent cervical cancer. Chinese German J Clin Oncol 6:282–4.
  • Thomas GM. (1999). Improved treatment for cervical cancer–concurrent chemotherapy and radiotherapy. N Engl J Med 340:1198–200.
  • Thomas GM. (2000). Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiation Onchol 10:44–50.
  • Waggoner SE. (2003). Cervical cancer. Lancet 361:2217–25.
  • Wang X, Shen Y, Zhao Y, et al. (2015). Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: a phase II trial. Eur J Surg Oncol 41:1082–8.
  • Wu Z, Zou X, Yang L, et al. (2014). Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer. Colloids Surf B Biointerfaces 122:90–8.
  • Yao T, Lu R, Li Y, et al. (2015). ALDH1 might influence the metastatic capability of HeLa cells. Tumor Biol 36:7045–51.
  • Yapp DT, Lloyd DK, Zhu J, Lehnert SM. (1998). The potentiation of the effect of radiation treatment by intratumoral delivery of cisplatin. Int J Radiation Oncol Biologyphys 42:413–20.
  • Yu Y, Xu S, You H, et al. (2017). In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma. Drug Deliv 24:75–82.
  • Zhang X, Yang H, Gu K, et al. (2011). In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer. Int J Nanomed 6:437–44.
  • Zhou F, Cui C, Ge Y, et al. (2010). Alpha2,3-Sialylation regulates the stability of stem cell marker CD133. J Biochem 148:273–80.